Axa (AXAHY) Upgraded to Buy: What Does It Mean for the Stock?

17.03.26 17:00 Uhr

Werte in diesem Artikel
Aktien

40,14 EUR 0,08 EUR 0,20%

Indizes

7.962,4 PKT -18,9 PKT -0,24%

609,5 PKT -2,7 PKT -0,44%

5.692,9 PKT -39,9 PKT -0,70%

1.768,2 PKT -3,9 PKT -0,22%

3.519,6 PKT -17,6 PKT -0,50%

10.007,5 PKT -1,8 PKT -0,02%

6.033,1 PKT -13,0 PKT -0,21%

4.967,2 PKT -10,5 PKT -0,21%

Axa Sa (AXAHY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.Therefore, the Zacks rating upgrade for Axa basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.For Axa, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .Earnings Estimate Revisions for AxaFor the fiscal year ending December 2026, this company is expected to earn $4.73 per share, which is unchanged compared with the year-ago reported number.Analysts have been steadily raising their estimates for Axa. Over the past three months, the Zacks Consensus Estimate for the company has increased 2%.Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.You can learn more about the Zacks Rank here >>> The upgrade of Axa to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.See Our Newest 5 Stocks Set to Double Picks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Axa Sa (AXAHY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Quelle: Zacks

Nachrichten zu AXA S.A.

Analysen zu AXA S.A.

DatumRatingAnalyst
23.03.2026AXA OverweightBarclays Capital
05.03.2026AXA BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
03.03.2026AXA BuyGoldman Sachs Group Inc.
02.03.2026AXA OutperformRBC Capital Markets
02.03.2026AXA BuyDeutsche Bank AG
DatumRatingAnalyst
23.03.2026AXA OverweightBarclays Capital
05.03.2026AXA BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
03.03.2026AXA BuyGoldman Sachs Group Inc.
02.03.2026AXA OutperformRBC Capital Markets
02.03.2026AXA BuyDeutsche Bank AG
DatumRatingAnalyst
03.03.2025AXA NeutralGoldman Sachs Group Inc.
27.02.2025AXA NeutralGoldman Sachs Group Inc.
29.01.2025AXA NeutralGoldman Sachs Group Inc.
01.11.2024AXA NeutralGoldman Sachs Group Inc.
31.10.2024AXA NeutralGoldman Sachs Group Inc.
DatumRatingAnalyst
10.05.2017AXA VerkaufenDZ BANK
02.08.2016AXA UnderperformMacquarie Research
23.01.2015AXA UnderweightJP Morgan Chase & Co.
12.01.2015AXA UnderweightJP Morgan Chase & Co.
19.11.2014AXA UnderweightJP Morgan Chase & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für AXA S.A. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen